Insmed, Inc. (INSM) Reports Q3 Loss of $1.39, Sales Fall Y/Y
Tweet
Share
E-mailGet Alerts INSM Hot Sheet
Price: $126.29 -0.31%
EPS Growth %: +78.3%
Financial Fact:
Net loss attributable to common stockholders: -37.76M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +78.3%
Financial Fact:
Net loss attributable to common stockholders: -37.76M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Insmed, Inc. (NASDAQ: INSM) reported Q3 EPS of ($1.39), versus ($0.03) reported last year. Revenue for the quarter came in at $400 thousand, versus $1.8 million reported last year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ambarella (AMBA) Tops Q2 EPS by 1c; offers guidance
- Planet Labs (PL) Tops Q2 EPS by 4c, Offers Guidance
- Guidewire Software (GWRE) Tops Q4 EPS by 6c; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
